| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |